Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 May;84(9):2911-5.
doi: 10.1073/pnas.84.9.2911.

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients

P O Livingston, E J Natoli, M J Calves, E Stockert, H F Oettgen, L J Old

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients

P O Livingston et al. Proc Natl Acad Sci U S A. 1987 May.

Abstract

GM2, GD2, and GD3 gangliosides are expressed on the surface of human melanoma cells and represent potential targets for immunological control of melanoma growth by monoclonal antibodies and active immunization. The immunogenicity of GM2 was investigated by analyzing the humoral immune response of melanoma patients to vaccination with cell lines selected for high GM2 expression and with vaccines containing purified GM2. The whole-cell vaccine and vaccines containing purified GM2 and bacillus Calmette-Guérin (BCG) elicited GM2 antibody in a high proportion of patients, particularly in GM2/BCG-vaccinated patients pretreated with cyclophosphamide and given a GM2/BCG booster immunization. Vaccines containing purified GM2 and Salmonella minnesota R595 as the adjuvant were also effective, but only in patients pretreated with cyclophosphamide. GM2 antibodies in vaccinated patients were of the IgM class and were cytotoxic for GM2-positive targets in the presence of human complement.

PubMed Disclaimer

References

    1. Eur J Biochem. 1971 Dec 22;24(1):116-22 - PubMed
    1. Int J Cancer. 1979 Jul 15;24(1):34-44 - PubMed
    1. J Neurol Sci. 1980 May;46(2):179-86 - PubMed
    1. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6114-8 - PubMed
    1. Cancer Res. 1981 Feb;41(2):361-75 - PubMed

Publication types